These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37175741)

  • 21. CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1.
    Pan J; Lin M; Xu Z; Xu M; Zhang J; Weng Z; Lin B; Lin X
    Carcinogenesis; 2021 Nov; 42(11):1399-1409. PubMed ID: 34436551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumol Inhibits Growth and Induces Apoptosis of Colorectal Cancer LoVo Cell Line via IGF-1R and p38 MAPK Pathway.
    Wang J; Huang F; Bai Z; Chi B; Wu J; Chen X
    Int J Mol Sci; 2015 Aug; 16(8):19851-67. PubMed ID: 26307972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
    Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
    Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug.
    Bagheri M; Tabatabae Far MA; Mirzaei H; Ghasemi F
    Fundam Clin Pharmacol; 2020 Feb; 34(1):51-64. PubMed ID: 31233627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total saponins from Rhizoma Panacis Majoris inhibit proliferation, induce cell cycle arrest and apoptosis and influence MAPK signalling pathways on the colorectal cancer cell.
    Chang L; Zhou R; He Y; Meng M; Hu J; Liu Y; Pan Y; Tang Z; Yue Z
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway.
    Chen L; Jiang K; Chen H; Tang Y; Zhou X; Tan Y; Yuan Y; Xiao Q; Ding K
    Cancer Manag Res; 2019; 11():95-105. PubMed ID: 30588113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
    Sever B; Altıntop MD; Çiftçi GA; Özdemir A
    Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RBP-J promotes cell growth and metastasis through regulating miR-182-5p-mediated Tiam1/Rac1/p38 MAPK axis in colorectal cancer.
    Li F; Zhou YD; Liu J; Cai JD; Liao ZM; Chen GQ
    Cell Signal; 2021 Nov; 87():110103. PubMed ID: 34339855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
    Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
    J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
    El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
    Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.
    Wang C; Yang M; Gu X; Gu Y
    Bioengineered; 2021 Dec; 12(1):6594-6605. PubMed ID: 34516351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy.
    de Almeida LC; Carlos JAEG; Rezende-Teixeira P; Machado-Neto JA; Costa-Lotufo LV
    Life Sci; 2022 Nov; 308():120911. PubMed ID: 36030982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells.
    Yin J; Wang C; Tang X; Sun H; Shao Q; Yang X; Qu X
    Mol Med Rep; 2013 Dec; 8(6):1630-4. PubMed ID: 24126760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells.
    He LJ; Yang DL; Li SQ; Zhang YJ; Tang Y; Lei J; Frett B; Lin HK; Li HY; Chen ZZ; Xu ZG
    Bioorg Med Chem; 2018 Aug; 26(14):3899-3908. PubMed ID: 29921474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl Sartortuoate Inhibits Colon Cancer Cell Growth by Inducing Apoptosis and G2/M-Phase Arrest.
    Lan Q; Li S; Lai W; Xu H; Zhang Y; Zeng Y; Lan W; Chu Z
    Int J Mol Sci; 2015 Aug; 16(8):19401-18. PubMed ID: 26287184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents.
    Zhu H; Ying S; Zhou B; Hu X; Liang X; Li W; Wang D; Jin H; Pan Y
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):593-604. PubMed ID: 33557648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Peptide Derived from
    Li C; Zhang S; Zhu J; Huang W; Luo Y; Shi H; Yu D; Chen L; Song L; Yu R
    Mar Drugs; 2022 Jan; 20(2):. PubMed ID: 35200639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.
    Fiore D; Proto MC; Pisanti S; Picardi P; Pagano Zottola AC; Butini S; Gemma S; Casagni A; Laezza C; Vitale M; Ligresti A; Di Marzo V; Zisterer DM; Nathwani S; Williams DC; Campiani G; Gazzerro P; Bifulco M
    Cancer Biol Ther; 2016 Aug; 17(8):849-58. PubMed ID: 26392056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
    Qu M; Li J; Yuan L
    Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.